2. Reg allocation per stock. Assume maximum 35 Core stocks and 25 Smallcap ones. Take total long term budget as X for Core & Y for SmallCap. (Based on ones risk profile, Y can be lower or equal to X. Smallcap stocks have inherent higher risks) Read more:
4. 2nd Dec 2020 on the Adani Group! This is the first prediction by any market expert, on the expected mega transformation of Adani Group. And it is happening!
5. This was the first time I head of a business group being announced as an incubator of group companies! Quite diff from the usual startup incubator. "Adani Enterprises will incubate and demerge a number of companies maximising shareholder value"
10. 15% Range & Not being Selective in entry. Concept of - Entering only within 15% of Sumitji's entry rate. And concept of not being "selective" in stock entry. (This will take care of non performers & protect overall portfolio gain)
15. Missing ones to be added later. Hope you will find this thread useful!
16. Most mistakes are a)Over loading on a stock b) Buying far outside 15% limit c) Skipping entries d) Not building BALANCED portfolio with new entries. Assume a 10 stock portfolio. If 5 do not perform too, pf wd succeed. If someone buys only 4 and they are part of nonperformers?
17. Allocation levels. Core at level A. Smallcap& IPO at level B. Also when longterm budget increases, I will allocate higher for new Core as well as Smallcap/IPO leaving old stocks, at their old allocation level. SME & certain exceptional stocks will be at totally diff levels
• • •
Missing some Tweet in this thread? You can try to
force a refresh
On 29th April, @niftygranmaster added #BetaDrugs to his portfolio. The first SME stock. He had posted on 24th about the potential of companies, working on cancer cure. Let’s now take a deeper look at Beta Drugs and review its growth potential
2/ The company’s growth has indeed taken off in FY22.
FY 2018 - Rs.50 Crores
FY 2019 - Rs.64 Crores
FY 2020 - Rs.90 Crores
FY 2021 - Rs.116 Crores
FY 2022 - Rs.183 Crores
Net profit in FY22 more than doubled to Rs.25Crore with EPS at Rs.26.
3/ Beta Drugs had fully acquired Adley Formulation Pvt Ltd (AFPL) and Adley Lab Ltd (ADL) resulting in backward integration of APIs & other raw materials. This has made key difference in its operating margins and revenues.
On 13th April, @NiftyGranmaster entered #DYNACONS. What do we know about the naughty little animal that Sumitji unleashed on 14th April? It went berserk running up, 20% in a day! Dynacons Systems & Solutions Ltd. #DSSL Follow this thread...🧵
2/ #DSSL is growing fast and is getting ready to fight the big guns as well as the fragmented local service providers, in the IT Infrastructure Industry. Founded in 1995, it has stuck it out and grown slowly but steadily and has reached a stage where it can win larger contracts
3/ #Dynacons has built strong engineering skills and has the manpower to deliver services to large corporates, banks and industries, nationwide. It also has presence in Singapore for handling Asia Pacific operations #Multibaggers
Sadhana Nitro Chem - A Deep Dive. Let’s look deeper into the key products and the chemical process of @NiftyGranmaster's first FBB pick! Spotting upcoming industry winners is no mean task. And #SumitBansal ji is turning out to be a grand master at this! Time and again! 1/
Sadhana Nitro Chem is not a new kid on the block. It was established in 1973 and has been in the forefront of Nitrobenzene (NB) production in India. The company also has a wholly owned subsidiary in Belgium, catering to the European market. 2/
During 50 years of its operation, it has fined tuned its technology and stayed strong. The decades of struggle, manufacturing the highly toxic NB and its derivatives has helped to make it a very hard nut to crack. 3/
Sadhana Nitro. Why is it an FBB stock as described by @NiftyGranmaster? Let's analyze! The company is a well established player in the chemical industry with strong presence in Nitrobenzine and it's derivatives. #Multibagger#SumitBansal 1/
It is venturing into production of Para AmminoPhenol (PAP) a highly sought after chemical in the global market, due to reduction of around 60000 TPA capacity in China. Sadhana is setting up a 36000 TPA plant to meet this shortfall.
2/
Most importantly, Sadhana will use Nitrobenzine as feedstock unlike the Para Nitro Chloro Benzene (PNCB) route used by majority of Chinese players and Valiant Chem in India.
3/